Is ADXN or AGEN more undervalued in 2026?

CirclFi compares Addex Therapeutics Ltd (ADXN) and Agenus Inc. (AGEN) using 13 institutional-grade valuation models. ADXN has a Quality of Company score of 5.5/10 while AGEN scores 4.8/10.

Which is a better buy — ADXN or AGEN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ADXN and AGEN valuations compare?

ADXN at $6.82 and AGEN at $3.40 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ADXN vs AGEN Valuation Comparison 2026 — Intrinsic Value Analysis

ADXN

Biotechnology

Addex Therapeutics Ltd

Quality

5.5

out of 10

Value Trap

SAFE

Price

$6.82

Last close

Models

6/13

Active

AGEN

Biotechnology

Agenus Inc.

Quality

4.8

out of 10

Value Trap

WARN

Price

$3.40

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	ADXN Fair Value	ADXN Upside	AGEN Fair Value	AGEN Upside
Bayesian DCF	Intrinsic	—	—	$11.25	+230.8%
Earnings Power Value	Intrinsic	—	—	$2.25	-33.7%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$13.22	+88.8%	$3.64	+7.0%
Dynamic NAV	Asset-Based	$6.04	-11.4%	$7.13	+109.7%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ADXN vs AGEN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ADXN vs AGEN — Which Stock Is More Undervalued?

ADXN scores higher with a 5.5/10 quality rating vs AGEN's 4.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Addex Therapeutics Ltd (ADXN) and Agenus Inc. (AGEN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ADXN currently trades at $6.82 with a QOC of 5.5/10, while AGEN trades at $3.40 with a QOC of 4.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).